arrow
M

Minneke J. Coenraad

Leiden University
H指数:30
被引数:5,155

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Increasing incidence and changing trends in etiology & survival rates in HCC in a European cohort

欧洲队列中肝细胞癌发病率增加及病因与生存率变化趋势

2026-06-230
OA
Dipstick urinary chloride as a surrogate marker of urinary sodium in cirrhosis: a prospective multicenter pilot study

尿氯试纸作为肝硬化患者尿钠的替代标志物:一项前瞻性多中心试点研究

2026-06-010
OAAI
Radiological classification of non-anastomotic biliary strictures after liver transplantation

肝移植术后非吻合口胆道狭窄的放射学分类

2026-04-170
OA
Development and patterns of acute-on-chronic liver failure in patients with cirrhosis and acute kidney injury

急性-慢性肝功能衰竭在肝硬化合并急性肾损伤患者中的发展与模式

2026-01-120
OAAI
Simultaneous Liver-Kidney Transplantation versus Liver Transplantation in End-Stage Liver Disease Patients with Kidney Dysfunction

终末期肝病合并肾功能不全患者中肝肾联合移植与单独肝移植的比较

2026-01-011
OA
Serum Villin-1-A Novel Marker of Gut Barrier Damage in Acutely Decompensated Cirrhosis: A Cohort Study and Validation

血清Villin-1—肝硬化急性失代偿期肠道屏障损伤的新型标志物:一项队列研究及验证

2025-12-010
OAAI
Long-term Follow-up After Hypothermic Oxygenated Machine Perfusion in DCD Liver Transplantation: Results of a Randomized Controlled Multicenter Trial (DHOPE-DCD)

低温氧合机器灌注在DCD肝移植后的长期随访:一项随机对照多中心试验(DHOPE-DCD)的结果

2025-08-050
OAAI
The Vasopressin Biomarker Copeptin Is Linked to Systemic Inflammation and Refines Prognostication in Decompensated Cirrhosis

Hartl, L.; Hintersteininger, M.; Simbrunner, B.; Jachs, M.; Hofer, B.S.; Bauer, D.J.M.; Dominik, N.; Schwarz, M.; Balcar, L.; Kramer, G.; 等. 血管加压素生物标志物copeptin与系统性炎症相关,并改进了失代偿期肝硬化的预后判断。Clin. Gastroenterol. Hepatol. 2025, S1542356525004616. [Google Scholar] [CrossRef]

2025-06-020
OAAI
Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision framework
2024-09-010
PRE
MRI-serum-based score accurately identifies patients undergoing liver transplant without rejection avoiding the need for liver biopsy: A multisite European study
2024-08-232
OAAI
Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis
2024-02-275
OAAI
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial)
2024-02-082
OAAI
Intraprocedural assessment of ablation margins using computed tomography co-registration in hepatocellular carcinoma treatment with percutaneous ablation: IAMCOMPLETE study
2024-02-012
OAAI